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Abstract
Liver angiosarcoma is a rare disease, however it still ranks as the third of most common primary liver maligancies.
The prognosis of liver angiosarcoma is very poor with almost all patients with this kind of disease die within 2
years after diagnosis. No specific symptoms and signs are closely associated with this disease. Here, we report a
case presenting shock status at first due to rupture of liver angiosarcoma- induced internal bleeding. After
emergent transarterial embolization (TAE), she received partial hepatectomy two weeks later. 4 months after
operation, she is still with a good performance status without obvious recurrence or metastasis identified.
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Background
Hepatic angiosarcoma is a very rare disease, accounting
for only 2% of primary liver malignancy [1-3]; however,
it still ranks as the third place in the list of most com-
mon primary liver malignancies [2,3]. Hepatic angiosar-
coma originates from endothelial cells and usually
presents as an abdominal mass with unspecific symp-
toms and signs [4], making it difficult to diagnose in the
early stage. The survival of hepatic angiosarcoma is very
poor, which is attributable to its rapid progress, high
recurrence rate, and resistant to traditional chemother-
apy and radiotherapy [5-7]. Even liver transplantation
could not benefit patients with liver angiosarcoma [8].
To date, the therapeutic guideline for liver angiosarcoma
has not been set up; partial liver resection to remove
tumor radically still remains to be the cornerstone of
treatment options. Here we reported a case with pri-
mary liver angiosarcoma presenting with hemoperito-
neum due to tumor rupture and active bleeding treated
by TAE and subsequent partial liver resection.
Case presentation
An 83 year-old female complained about lower abdo-
men pain for two months. After one episode of fierce
right upper abdomen pain occurred on July 12
th, 2011,
she was brought to our emergency department for aid
by her families. In our emergency department (ER),
unstable systolic blood pressure of 90 mmHg with
tachycardia of 110 beats/min was found. Resuscitation
was then given. Subsequent blood examination showed
leukocytosis (161000/μL), anemia (9 g/dL), and throm-
bocytopenia (85000/μL). Abdomen distension with mild
tenderness while pressed was also noted. Under the
impression of internal bleeding, bedside echo was then
conducted, which revealed intra-abdomen fluid accumu-
lation and a liver mass. Abdomen computer tomography
(CT) was thereafter arranged for this patient with con-
trast injection, which indicated a 3 cm hypervascular
mass over segment 5 of liver with active bleeding (Fig-
ure 1). An emergent angiogram of celiac trunk was then
conducted and showed a hypervascular tumor at the
right lobe of liver which was supplied by the right hepa-
tic artery. Extravastion of contrast medium from the
tumor surface was shown which indicated an active
tumor bleeding (Figure 2A). Then emergent emboliza-
tion was done after superselective cannulation into the
feeders using a 3 Fr. Microcatheter from the S5 branch
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powder (200 um) mixed with contrast medium were
infused via the feeders into the right lobe tumor until
the flow stasis. Post-embolization angiogram showed
that no extravastion of the contrast medium from the
right lobe tumor (Figure 2B). After admission, thorough
liver function tests and hepatitis survey were done. This
patient’s liver function was categorized as Child Pugh A
and no hepatitis was diagnosed. Alpha-fetoprotein, CEA,
CA 19-9 were within normal range. Under the impres-
sion of liver tumor, highly suspected as a hepatoma
based on findings in TAE and abdominal CT of this
patient, laparotomy were performed two weeks later
after TAE. During operation, 2000 cc bloods inside
abdomen was found. A 3 cm tumor over surface of seg-
ment 5 of liver was noted. Partial hepatectomy of liver
segment 5 to remove tumor was done.
Pathological examination
The resected liver contained a tumor composed of ana-
stomosing vascular channels in an infiltrating growth
pattern. The vascular channels were lined by atypical
endothelial cells with enlarged hyperchromatic nuclei
(Figure 3). The other sections of resected liver showed
spindled or epithelioid tumor cells forming hemorrhagic
nests and sheets with rudimentary vascular channels.
The tumor cells possessed high grade nuclear atypia and
brisk mitotic activity(Figure 4). Epithelioid areas made
up of large rounded tumor cells with high grade nuclear
atypia and brisk mitotic activity were also seen (Figure
5). Immunohistochemically, the tumor cells expressed
usual vascular antigens CD31 and CD34 as well as
mesenchymal marker, Vimentin (Figure 6, 7, 8) [9,10].
The negative staining of HAS and GPC-3 excludes the
possibility of hepatocytic neoplasm(Figure 9, 10) [11,12].
Subsequently, a final diagnosis of liver angiosarcoma
was confirmed.
After operation, this patient recovered very well and
was discharged two weeks later. Adjuvant chemotherapy
and radiation were not given after taking the effective-
ness of them and her old age into consideration. No
local recurrence or distant metastasis has been found at
the time of writing, 4 months after operation. This
patient is now still with a good performance status.
Discussion
Angiosarcoma, a subtype of soft tissue sarcoma, is an
aggressive malignant disease deriving from endothelium,
lymphatics, or blood vessels. Angiosarcoma occurs most
commonly in head and neck, followed by breast. Liver
Figure 3 
Figure 1 Enhanced CT scan showed a ruptured irregular liver
mass. Enhanced CT scan showed a ruptured irregular liver mass
(balck arrow) with prominent enhancement at the liver surface
inducing contrast leakage into the right subphrenic space.
Figure 2A                                                                                                                                                          Figure 2B 
Figure 2 The celiac trunk angiogram showed a hypervascular mass in right lobe of liver with contrast extravastion from the tumor
surface (black arrow), which was compatible with CT findings of a hypervascular hepatic tumor bleeding. Figure 2B-After
embolization, no contrast extravastion from the tumor was shown.
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mon seen sites of angiosarcoma [9] and is very rare.
Liver angiosarcoma occurs in the elder mainly [1].
Although the symptoms are usually nonspecific, abdom-
inal distension and discomfort, weight loss, and fatigue
are commonly found [13,14]. Others like jaundice,
ascites, or hepatomegaly are usually associated with
advanced liver angiosarcoma [13,15]. The abnormal liver
functions found in advanced liver angiosarcoma are
attributable to the replacement of normal liver parench-
ema by tumor [16].
Due to the hypervascular characteristic of liver angio-
sarcoma, it is difficult to differentiate liver angiosarcoma
from other vascular tumors in liver, such as hepatoma
or adenoma, radiologically. As shown in the present
case, CT and angiogram all indicated a hypervascular
mass, which was in line with the image findings of hepa-
toma. After resection, pathologically, the resected liver
showed a tumor composed of anastomosing vascular
channels infiltrating surrounding hepatic tissue in a
destructive fashion. The channels were lined by atypical
endothelial cells with enlarged hyperchromatic nuclei.
Immunohistochemically, the tumor was positive for
CD31, CD34, and Vimentin, a mesenchymal marker,
&ŝŐƵƌĞϯ
Figure 3 The section of resected liver showed a tumor
composed of anastomosing vascular channels in an infiltrating
growth pattern. The section of resected liver showed a tumor
composed of anastomosing vascular channels in an infiltrating
growth pattern. The vascular channels are lined by atypical
endothelial cells with enlarged hyperchromatic nucle (black arrow).
&ŝŐƵƌĞϰ
Figure 4 The section of resected liver showed spindled tumor
cells forming hemorrhagic nests and sheets. The section of
resected liver showed spindled tumor cells forming hemorrhagic
nests and sheets. Rudimentary vascular channels were noted within
the tumor cell nest. The spindled tumor cells showed high grade
nuclear atypia with brisk mitotic activity(black arrows).
&ŝŐƵƌĞϱ
Figure 5 Epithelioid areas. Epithelioid areas made up of large
rounded tumor cells with high grade nuclear atypia and brisk
mitotic activity were also seen(black arrows).
&ŝŐƵƌĞϲ
Figure 6 Immunohistochemical study. Immunohistochemical
study showed that the tumor cells expressed vascular antigen CD31
strongly(black arrow, score 3+, clone 1A10, Novocastra).
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possibility of hepatocyte origin. Taken together, the liver
angiosarcoma was confirmed as the final diagnosis
[9-12].
The survival of patients with liver angiosarcoma is
very poor with media survival of 6 months without
treatment. Even after treatment, only 3% of patients
were reported to live longer than 2 years [3]. The rea-
sons contributing to this are complicated. First, due to
its nonspecific symptoms, the diagnosis is usually too
late, which excludes the chance of complete resection of
tumor in most cases. Second, liver angiosarcoma usually
presents with early metastases to other organs, such as
lung, spleen, or bone, which further worsens its prog-
nosis. At present, the standard treatment for liver angio-
sarcoma remains surgical resection. Others such as
chemotherapy or radiotherapy fails to reach a conclusive
benefit on survival of liver angiosarcoma [5-7], although
chemotherapy is the critical part of treatments of soft
tissue sarcoma and radiotherapy plays a palliative role in
liver metastasis [17]; Liver transplantation is also not
deemed feasible to treat liver angiosarcoma thanks to its
high recurrent rate and still poor survival after trans-
plantation [8].
Liver angiosarcoma also easily induces severe intraab-
dominal hemorrhage due to spontaneous rupture, lead-
ing to subsequent tumor cell spillage and peritoneal
tumor seeding, which further complicates the prognosis
&ŝŐƵƌĞϳ
Figure 7 Immunohistochemical study. Immunohistochemical
study revealed that the tumor cells was strongly positive for
vascular antigen CD34 (black arrow, score 3+, clone QBEnd-10,
Dako).
&ŝŐƵƌĞϴ
Figure 8 Immunohistochemical study. Immunohistochemical
study demonstrated that the tumor cells strongly expressed the
mesenchymal marker, Vimentin (black arrow, score 3+, clone V9,
Novocastra).
&ŝŐƵƌĞϵ
Figure 9 Immunohistochemical study. Immunohistochemical
study revealed negative staining of hepatocyte paraffin antibody
(HAS, clone OCH1E5, CellMarque) over tumor cells (black arrow).
&ŝŐƵƌĞϭϬ
Figure 10 Immunohistochemical study. Immunohistochemical
study showed negative staining of Glypican-3 (GPC-3, clone 1G12,
Bio SB) over tumor cells (black arrow).
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ing happens, TAE is usually the first choice to stop the
bleeding and to get the patients stable [18,19]. Other-
wise, in relatively stable patients, conservative treatment
may also work in this situation [2]. However, due to the
rare incidence of liver angiosarcoma, how to treat acute
bleeding of liver angiosarcoma has not yet reached a
definite conclusion at present. As shown in the present
case, spontaneous liver angiosarcoma rupture made her
present with a shock status at first. After embolizaton
and resuscitation, her condition got stabilized and she
received partial hepatectomy two weeks later. For this
patient, the poor prognosis is expected according to pre-
vious reports. However, given that this patient is already
83 years old and no effective strategies against liver
angiosarcoma are available so far, no more adjuvant
therapy has been given to this patient. No recurrence or
metastasis has been identified at the time of writing and
she is still with a good performance status so far, 4
months after operation.
Conclusion
Seeking a new strategy in addition to surgical resection
to treat liver angiosarcoma should be prioritized due to
its high recurrence rate and very dismal prognosis. Since
traditional chemotherapy and radiotherapy could not
benefit this kind of patients, combined with the rapid
progress of current molecular biology, target therapy
may be the further direction against liver angiosarcoma
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